All Stories

  1. Impact evaluation of the modified adverse inpatient medication event (AIME-Frail) model in hospitalised adults
  2. Evaluating the Effectiveness of Risk Categories for Prioritising Patients for Best Possible Medication History Completion at a Quaternary Hospital
  3. Remote patient monitoring outpatient telepharmacy services: A systematic review
  4. Pharmacist-Led Transition of Care Services in Patients with Cardiovascular Disease: A Systematic Scoping Review
  5. Telephone versus video consultations: A systematic review of consumer and provider preferences
  6. A post-discharge pharmacist clinic to reduce hospital readmissions: a retrospective cohort study
  7. Smoking cessation support preferences among people released from smoke-free prisons in Queensland, Australia
  8. ‘Don't Assume, Ask’: A Collaboration With Consumers, Interpreters, Clinicians and Health Service Staff to Increase Video Telehealth in Culturally and Linguistically Diverse Groups
  9. Telehealth-facilitated palliative care enables more people to die at home: An analysis of clinical outcomes and service activity data
  10. Trust and confidence in telehealth-delivered services: a nation-wide cross-sectional study
  11. A cost-consequence analysis of the Queensland specialist palliative rural telehealth (SPaRTa) service
  12. Utilizing technology for diet and exercise change in complex chronic conditions across diverse environments (U-DECIDE): feasibility randomised controlled trial
  13. The adverse inpatient medication event and frailty (AIME-frail) risk prediction model
  14. A systematic review of synchronous telepharmacy service models for adult outpatients with cancer
  15. Systematic review and meta-analysis of text messaging interventions to support tobacco cessation
  16. Economic evaluations of telepharmacy services in non-cancer settings: A systematic review
  17. It Was Like Going to a Battlefield: Lived Experience of Frontline Nurses Supporting Two Hospitals in Wuhan During the COVID-19 Pandemic
  18. Patients’ acceptability of self-selected digital health services to support diet and exercise among people with complex chronic conditions: Mixed methods study
  19. General practitioner preferences for telehealth consultations in Australia: a pilot survey and discrete choice experiment
  20. Cost-effectiveness of remote patient monitoring for First Nations peoples living with diabetes in regional Australia
  21. Development and validation of the Digital Health Acceptability Questionnaire
  22. Does the requirement for an interpreter impact experience with telehealth modalities, acceptability and trust in telehealth? Results from a national survey including people requiring interpreter services
  23. A cross-sectional study exploring equity of access to telehealth in culturally and linguistically diverse communities in a major health service
  24. Digital health literacy to enhance workforce skills and clinical effectiveness: A response to ‘Digital health literacy: Helpful today, dependency tomorrow? Contingency planning in a digital age’
  25. Pharmacist vs machine: Pharmacy services in the age of large language models
  26. Gestational diabetes mellitus care re‐imagined – A cost‐minimisation analysis: Cost savings from a tertiary hospital, using a novel, digital‐based gestational diabetes management model
  27. Introducing a Digital Occupational Violence Risk Assessment Tool Into an Emergency Department: A Pilot Implementation Study
  28. Artificial intelligence: Augmenting telehealth with large language models
  29. The roles and perspectives of an informatics pharmacist practicing in the Australian healthcare setting: a qualitative study
  30. Cost-effectiveness of telehealth-delivered nutrition interventions: a systematic review of randomized controlled trials
  31. How do consumers prefer their care delivered: In-person, telephone or videoconference?
  32. Inter-rater reliability of the occupational violence risk assessment tool for emergency departments
  33. Assessing the Effect of an Inpatient Smoking Cessation Brief Intervention Tool on Long-Term Smoking Cessation Rates and Patient Interest for Nicotine Replacement Therapy: A Retrospective Analysis
  34. Medicare reimbursed telehealth exercise physiology services were underutilised through the coronavirus (COVID-19) pandemic: an ecological study
  35. An evaluation of telephone versus videoconference consults for pre-treatment medication history taking by cancer pharmacists
  36. Costs to the Medicare Benefits Schedule for general practitioner consultations: A time-series analysis
  37. Dementia ECHO: Evaluation of a telementoring programme to increase dementia knowledge and skills in First Nations-led health services
  38. Health literacy, dementia knowledge and perceived utility of digital health modalities among future health professionals
  39. Three-dimensional (3D) printing for post-traumatic orbital reconstruction, a systematic review and meta-analysis
  40. Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: A multi-method study
  41. The impact of telehealth policy changes on general practitioner consultation activity in Australia: a time-series analysis
  42. Pharmacists reducing medication risk in medical outpatient clinics: a retrospective study of 18 clinics
  43. Increase in telemental health services on the Medicare Benefits Schedule after the start of the coronavirus pandemic: data from 2019 to 2021
  44. Telehealth sustainability after COVID-19 – can you see me by video?
  45. How have temporary Medicare telehealth item numbers impacted the use of dietetics services in primary care settings?
  46. Are Telehealth-Delivered Nutrition Care Interventions Cost-Effective for Managing Chronic Diseases? A Systematic Review of All Payer Perspectives
  47. Economic Evaluations of Remote Patient Monitoring for Chronic Disease: A Systematic Review
  48. Implications of increased telehealth use on organisations providing mental health services during COVID-19
  49. Infusion reaction incidence after switching all patients to an infliximab biosimilar in an Australian hospital
  50. Benefits, challenges and contributors to the introduction of new hospital-based outpatient clinic pharmacist positions
  51. Quantifying the Societal Benefits From Telehealth: Productivity and Reduced Travel
  52. Validity and reliability of the novel three‐item occupational violence patient risk assessment tool
  53. Associations between mental illness and non-medical use of prescription opioids among a sample of people who use drugs in Australia and New Zealand
  54. Mental illnesses as a potential risk factor for non‐medical use of prescription opioids: a narrative review
  55. Is the use of ranitidine required as a pre‐medication to prevent hypersensitivity reactions to paclitaxel?
  56. Smoking status on subsequent readmission to hospital: The impact of inpatient brief interventions for smokers
  57. The right time and place: the need for seven‐day pharmacist service models
  58. GP perceptions of telehealth services in Australia: a qualitative study
  59. Changing from telephone to videoconference for pre-treatment pharmacist consults in cancer services: Impacts to funding and time efficiency
  60. Enhancing a community palliative care service with telehealth leads to efficiency gains and improves job satisfaction
  61. Optimising specialist geriatric medicine services by telehealth
  62. Specialist consultation activity and costs in Australia: Before and after the introduction of COVID-19 telehealth funding
  63. Economic evaluations of videoconference and telephone consultations in primary care: A systematic review
  64. Infliximab switching from reference product to biosimilar: a review of evidence regarding the clinical efficacy, safety profile and immunogenicity
  65. Text automation tool to improve pharmacist productivity and work capacity in a digital hospital: a pilot study
  66. Consumer Preference and Willingness to Pay for Direct-to-Consumer Mobile Teledermoscopy Services in Australia
  67. Factors influencing the effectiveness of remote patient monitoring interventions: a realist review
  68. An evaluation of pharmacist activity in hospital outpatient clinics
  69. Why telehealth does not always save money for the health system
  70. Does the Choice Between a Telehealth and an In-Person Appointment Change Patient Attendance?
  71. An overview of the effect of telehealth on mortality: A systematic review of meta-analyses
  72. The clinical effectiveness of telehealth: A systematic review of meta-analyses from 2010 to 2019
  73. Patient preferences for specialist outpatient video consultations: A discrete choice experiment
  74. Addressing concerns and adapting psychological techniques for videoconsultations: a practical guide
  75. What can we do about occupational violence in emergency departments? A survey of emergency staff
  76. Does remote patient monitoring reduce acute care use? A systematic review
  77. Exploring paramedics’ intention to use a specialist palliative care telehealth service
  78. Paying for Telemedicine After the Pandemic
  79. A Systematic Review and Meta-Analysis of Change in Health-Related Quality of Life for Interactive Telehealth Interventions for Patients With Asthma
  80. A retrospective review examining intravenous iron infusion dosing methods
  81. The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis
  82. Skin Doctor Consultations Using Mobile Teledermoscopy: Exploring Virtual Care Business Models
  83. Determining if Telehealth Can Reduce Health System Costs: Scoping Review
  84. An audit of the quantity of immediate release oxycodone 5 mg tablets prescribed for discharge: an area for improved opioid stewardship?
  85. Economic benefits of pharmacy technicians practicing at advanced scope: A systematic review
  86. Building on the momentum: Sustaining telehealth beyond COVID-19
  87. Long-term effects of childhood speech and language disorders: A scoping review
  88. Evaluating the utility of a Smoking Cessation Clinical Pathway tool to promote nicotine prescribing and use among inpatients of a tertiary hospital in Brisbane, Australia
  89. Nicotine vaping products as a harm reduction tool among smokers: Review of evidence and implications for pharmacy practice
  90. Transit Care Hub pharmacist: improving patient flow within the hospital
  91. A Systematic Review of Pediatric Telediabetes Service Models
  92. Economic Advantages of Telehealth and Virtual Health Practitioners: Return on Investment Analysis
  93. Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data
  94. Commentary on Conigrave et al . (2020): Meta‐analysis of drinking patterns in Aboriginal and Torres Strait Islander populations highlights policy and research opportunities
  95. Current Economic Evidence for Teledermoscopy
  96. The Role of Telehealth in Reducing the Mental Health Burden from COVID-19
  97. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)
  98. Integrating a pharmacist into the perioperative setting
  99. Is Teledermoscopy Ready to Replace Face-to-Face Examinations for the Early Detection of Skin Cancer? Consumer Views, Technology Acceptance, and Satisfaction with Care
  100. Accuracy checking of dispensed medications by a pharmacy technician: a hospital case study
  101. Telehealth uptake in general practice as a result of the coronavirus (COVID-19) pandemic
  102. The breakeven point for implementing telehealth
  103. A cost-consequence analysis comparing patient travel, outreach, and telehealth clinic models for a specialist diabetes service to Indigenous people in Queensland
  104. Immersive Virtual Reality in Health Care: Systematic Review of Technology and Disease States
  105. A meta-analysis of pharmacists and pharmacy technicians’ accuracy checking proficiency
  106. A Commentary on the Dose–Response Relationship of Alcohol and Injury: Effects of Country‐Level Drinking Patterns and Alcohol Policies
  107. Pharmacy-led ward-based education reduces pharmaceutical waste and saves money
  108. Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia
  109. What do Australian dermatologists expect to be paid for store-and-forward teledermoscopy? A preliminary investigation
  110. Cost-effectiveness of Skin Cancer Referral and Consultation Using Teledermoscopy in Australia
  111. Economic evaluation strategies in telehealth: Obtaining a more holistic valuation of telehealth interventions
  112. Inpatient smoking cessation - turn to your clinical pharmacist
  113. Knowledge and attitudes of final year pharmacy students toward opioid substitution therapy
  114. Economics of teledermatology